Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Savvas Christoforidis

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
ACS Pharmacology & Translational Science|December 19, 2024
Developing MYC Degraders Bearing the Von Hippel-Lindau Ligand to Target the "Undruggable" MYCChristos Siokatas, Alexandra Lampropoulou, Alexandra Smina, et al.
Journal of Proteome Research|May 6, 2016
Proteome Changes during Transition from Human Embryonic to Vascular Progenitor CellsKonstantinos C Tsolis, Eleni Bagli, Katerina Kanaki, et al.
The Journal of Biological Chemistry|January 25, 2026
A new functional assay reveals that membrane binding is critical for overactivation of the phosphoinositide 3-kinase H1047R mutantAlexandra Papafotika, Maria Pavlaki, Vasiliki Lazani, et al.
Cellular Signalling|July 4, 2012
The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damageAlexandros Sfikas, Christina Batsi, Evangelia Tselikou, et al.
The Journal of Cell Biology|August 17, 2005
An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathwayHye-Won Shin, Mitsuko Hayashi, Savvas Christoforidis, et al.
Anti-Cancer Agents in Medicinal Chemistry|December 9, 2016
Discovery of New Aminosubstituted Pyrrolopyrimidines with Antiproliferative Activity Against Breast Cancer Cells and Investigation of their Effect Towards the PI3Kα EnzymeKonstantinos Daniilides, Nikolaos Lougiakis, Thomas Evangelidis, et al.
Molecular Cell|June 2, 2023
The Rab5 effector FERRY links early endosomes with mRNA localizationJan S Schuhmacher, Susanne Tom Dieck, Savvas Christoforidis, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
ACS Pharmacology & Translational Science|December 19, 2024
Developing MYC Degraders Bearing the Von Hippel-Lindau Ligand to Target the "Undruggable" MYCChristos Siokatas, Alexandra Lampropoulou, Alexandra Smina, et al.
Journal of Proteome Research|May 6, 2016
Proteome Changes during Transition from Human Embryonic to Vascular Progenitor CellsKonstantinos C Tsolis, Eleni Bagli, Katerina Kanaki, et al.
The Journal of Biological Chemistry|January 25, 2026
A new functional assay reveals that membrane binding is critical for overactivation of the phosphoinositide 3-kinase H1047R mutantAlexandra Papafotika, Maria Pavlaki, Vasiliki Lazani, et al.
Cellular Signalling|July 4, 2012
The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damageAlexandros Sfikas, Christina Batsi, Evangelia Tselikou, et al.
The Journal of Cell Biology|August 17, 2005
An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathwayHye-Won Shin, Mitsuko Hayashi, Savvas Christoforidis, et al.
Anti-Cancer Agents in Medicinal Chemistry|December 9, 2016
Discovery of New Aminosubstituted Pyrrolopyrimidines with Antiproliferative Activity Against Breast Cancer Cells and Investigation of their Effect Towards the PI3Kα EnzymeKonstantinos Daniilides, Nikolaos Lougiakis, Thomas Evangelidis, et al.
Molecular Cell|June 2, 2023
The Rab5 effector FERRY links early endosomes with mRNA localizationJan S Schuhmacher, Susanne Tom Dieck, Savvas Christoforidis, et al.
Pageof 3